/
/
/

Suven Life Sciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹4 Cr₹2 Cr₹3 Cr₹92 L₹2 Cr₹1 Cr₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹9 Cr₹1 Cr₹9 Cr₹3 Cr₹274 Cr₹199 Cr₹253 Cr₹2 Cr₹90 Cr₹192 Cr
₹8 Cr₹7 Cr₹3 Cr₹4 Cr₹60 L₹1 Cr₹2 Cr₹4 Cr₹4 Cr₹4 Cr₹6 Cr₹5 Cr₹6 Cr₹6 Cr₹2 Cr₹21 L₹44 L₹12 L₹14 L₹50 L₹84 L₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹6 Cr₹6 Cr₹3 Cr₹4 Cr₹7 Cr₹7 Cr₹8 Cr
₹11 Cr₹8 Cr₹6 Cr₹5 Cr₹2 Cr₹3 Cr₹3 Cr₹7 Cr₹5 Cr₹7 Cr₹9 Cr₹8 Cr₹9 Cr₹8 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹11 Cr₹4 Cr₹12 Cr₹9 Cr₹280 Cr₹202 Cr₹257 Cr₹9 Cr₹96 Cr₹200 Cr
₹138 Cr₹54 Cr₹108 Cr₹82 Cr₹54 Cr₹47 Cr₹42 Cr₹56 Cr₹33 Cr₹34 Cr₹50 Cr₹28 Cr₹33 Cr₹36 Cr₹56 Cr₹28 Cr₹26 Cr₹25 Cr₹38 Cr₹30 Cr₹46 Cr₹24 Cr₹29 Cr₹28 Cr₹17 Cr₹35 Cr₹31 Cr₹178 Cr₹145 Cr₹184 Cr₹23 Cr₹85 Cr₹152 Cr
-₹125 Cr-₹44 Cr-₹101 Cr-₹76 Cr-₹50 Cr-₹43 Cr-₹38 Cr-₹48 Cr-₹27 Cr-₹26 Cr-₹40 Cr-₹18 Cr-₹22 Cr-₹26 Cr-₹49 Cr-₹21 Cr-₹21 Cr-₹20 Cr-₹32 Cr-₹27 Cr-₹42 Cr-₹20 Cr-₹25 Cr-₹15 Cr-₹12 Cr-₹22 Cr-₹22 Cr₹108 Cr₹62 Cr₹79 Cr-₹13 Cr₹17 Cr₹54 Cr
₹48 L₹16 L₹0₹0₹0₹0₹80,000₹2 L₹2 L₹3 L₹4 L₹4 L₹5 L₹5 L₹6 L₹7 L₹10 L₹10 L₹13 L₹15 L₹15 L₹24 L₹18 L₹26 L₹22 L₹23 L₹10 L₹2 Cr₹2 Cr₹2 Cr₹0₹59 L₹1 Cr
-₹128 Cr-₹46 Cr-₹102 Cr-₹77 Cr-₹52 Cr-₹44 Cr-₹39 Cr-₹50 Cr-₹28 Cr-₹28 Cr-₹42 Cr-₹13 Cr-₹24 Cr-₹28 Cr-₹51 Cr-₹23 Cr-₹16 Cr-₹21 Cr-₹34 Cr-₹28 Cr-₹39 Cr-₹22 Cr-₹26 Cr-₹17 Cr-₹13 Cr-₹23 Cr-₹23 Cr₹100 Cr₹55 Cr₹72 Cr-₹14 Cr₹11 Cr₹47 Cr
-₹128 Cr-₹46 Cr-₹102 Cr-₹77 Cr-₹52 Cr-₹44 Cr-₹39 Cr-₹50 Cr-₹28 Cr-₹27 Cr-₹42 Cr-₹13 Cr-₹24 Cr-₹28 Cr-₹51 Cr-₹23 Cr-₹16 Cr-₹21 Cr-₹34 Cr-₹28 Cr-₹39 Cr-₹22 Cr-₹24 Cr-₹16 Cr-₹10 Cr-₹26 Cr-₹23 Cr₹63 Cr₹26 Cr₹38 Cr-₹14 Cr₹4 Cr₹26 Cr

Share Price Live Stats

Open (₹)337.00
Volume (₹)2.77 L
High (₹)343.95
Upper Circuit402.50
Low (₹)336.80
Lower Circuit268.40
Prev Close335.45
52W High (₹)403.35
Price341.85
52W Low (₹)124.11

Share Market Cap & Key Ratios Overview

M.Cap (₹)9489.87 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.00
Price to Book8.07
Book Value16.46
EPS (TTM)-12.47
Face Value1.00
ROE (%)-101.81

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
SUVENNSE
LTP
1W Low
1W High
Market cap (₹)
1865+27.7 (1.51%)
1832.20
1891.50
4,42,437Cr
9624+249 (2.66%)
9312.50
9624
2,48,054Cr
4985+145 (3.00%)
4848.50
4992
1,89,842Cr
1170.1+10.1 (0.87%)
1152.10
1178
1,15,810Cr
1383-11.5 (-0.82%)
1364.50
1405.20
1,11,565Cr
2034+80 (4.09%)
1963.80
2037.20
1,08,338Cr
2465+164.3 (7.14%)
2303
2493
1,02,410Cr
1211.2+26.2 (2.21%)
1185
1222
1,01,163Cr
1721.5-12.5 (-0.72%)
1689.30
1738.90
97,642Cr
2102.8+19.8 (0.95%)
2080
2135
96,950Cr
341.85+0.3 (0.09%)
331.75
345.20
9,490Cr

Key Highlights of Suven Life Sciences Ltd’s P&L

In 2026-03-31, Suven Life Sciences Ltd reported total revenue of ₹21.04Cr, compared with ₹17.55Cr in 2025-03-31, reflecting Suven Life Sciences Ltd turnover.

Depreciation was ₹5.61Cr and finance costs were ₹30.53Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹276.34Cr in 2026-03-31 as compared to ₹-₹160.75Cr in 2025-03-31.

Net Profit (PAT) was ₹-₹276.34Cr in 2026-03-31 compared with ₹-₹160.75Cr in 2025-03-31.

Earnings per share (EPS) were ₹-10.48 in 2026-03-31, compared with ₹-7.37 in 2025-03-31.